Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Potassium Iodide | 3 | 2018 | 13 | 0.480 |
Why?
|
Alkaloids | 1 | 2013 | 190 | 0.420 |
Why?
|
Molecular Conformation | 3 | 2019 | 562 | 0.410 |
Why?
|
Azocines | 1 | 2011 | 18 | 0.400 |
Why?
|
Mesylates | 1 | 2009 | 36 | 0.360 |
Why?
|
Tosyl Compounds | 1 | 2009 | 113 | 0.340 |
Why?
|
Lasers, Gas | 2 | 2022 | 93 | 0.310 |
Why?
|
Photochemotherapy | 4 | 2020 | 807 | 0.310 |
Why?
|
Light | 7 | 2019 | 1374 | 0.300 |
Why?
|
Acinetobacter baumannii | 2 | 2021 | 107 | 0.300 |
Why?
|
Cross-Linking Reagents | 1 | 2009 | 694 | 0.280 |
Why?
|
Photosensitizing Agents | 3 | 2020 | 602 | 0.240 |
Why?
|
Gram-Positive Bacteria | 2 | 2016 | 185 | 0.240 |
Why?
|
Disinfection | 2 | 2016 | 191 | 0.230 |
Why?
|
Gram-Negative Bacteria | 2 | 2016 | 271 | 0.230 |
Why?
|
Thiazines | 2 | 2014 | 38 | 0.230 |
Why?
|
Titanium | 2 | 2016 | 494 | 0.230 |
Why?
|
Protein Folding | 1 | 2007 | 840 | 0.220 |
Why?
|
Models, Molecular | 4 | 2019 | 5451 | 0.220 |
Why?
|
Anti-Infective Agents | 3 | 2019 | 974 | 0.220 |
Why?
|
Fullerenes | 2 | 2019 | 14 | 0.210 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 4 | 2021 | 687 | 0.200 |
Why?
|
Lasers | 2 | 2018 | 952 | 0.190 |
Why?
|
Anti-Bacterial Agents | 6 | 2021 | 7182 | 0.190 |
Why?
|
Skin | 4 | 2022 | 4372 | 0.190 |
Why?
|
Pseudomonas aeruginosa | 3 | 2021 | 1219 | 0.190 |
Why?
|
Water | 1 | 2007 | 1395 | 0.180 |
Why?
|
Palladium | 2 | 2010 | 65 | 0.180 |
Why?
|
Sodium Nitrite | 1 | 2019 | 14 | 0.170 |
Why?
|
Carbapenems | 1 | 2020 | 118 | 0.170 |
Why?
|
Tetracyclines | 1 | 2018 | 60 | 0.160 |
Why?
|
Polyethylene Glycols | 2 | 2015 | 1182 | 0.160 |
Why?
|
Microbial Viability | 1 | 2019 | 234 | 0.150 |
Why?
|
Nitrates | 1 | 2019 | 265 | 0.150 |
Why?
|
Fluorouracil | 2 | 2022 | 1619 | 0.150 |
Why?
|
Molecular Structure | 2 | 2013 | 1899 | 0.150 |
Why?
|
Gram-Negative Bacterial Infections | 2 | 2016 | 232 | 0.140 |
Why?
|
Fungi | 2 | 2016 | 327 | 0.140 |
Why?
|
Bromides | 1 | 2016 | 20 | 0.140 |
Why?
|
Sodium Compounds | 1 | 2016 | 30 | 0.140 |
Why?
|
Fluorescent Dyes | 2 | 2016 | 1917 | 0.140 |
Why?
|
Carbocyanines | 1 | 2016 | 174 | 0.130 |
Why?
|
Biofilms | 2 | 2021 | 617 | 0.130 |
Why?
|
Respiratory System Agents | 1 | 2015 | 29 | 0.130 |
Why?
|
Skin Diseases, Bacterial | 1 | 2016 | 66 | 0.130 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2015 | 58 | 0.130 |
Why?
|
Oxazepines | 1 | 2015 | 18 | 0.130 |
Why?
|
Cell Tracking | 1 | 2016 | 145 | 0.120 |
Why?
|
Barbiturates | 1 | 2015 | 114 | 0.120 |
Why?
|
Porphyrins | 1 | 2016 | 348 | 0.120 |
Why?
|
Oxidation-Reduction | 2 | 2016 | 2184 | 0.120 |
Why?
|
Catalysis | 3 | 2010 | 762 | 0.120 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 1 | 2015 | 307 | 0.110 |
Why?
|
Encephalitis | 1 | 2016 | 425 | 0.110 |
Why?
|
Phototherapy | 1 | 2016 | 377 | 0.110 |
Why?
|
Drug Delivery Systems | 2 | 2015 | 2219 | 0.110 |
Why?
|
Oxazines | 1 | 2014 | 298 | 0.100 |
Why?
|
Microbial Sensitivity Tests | 4 | 2021 | 1877 | 0.100 |
Why?
|
Cisplatin | 1 | 2018 | 1662 | 0.100 |
Why?
|
Reactive Oxygen Species | 2 | 2016 | 2076 | 0.100 |
Why?
|
Femoral Vein | 1 | 2012 | 159 | 0.100 |
Why?
|
Pseudomonas Infections | 1 | 2016 | 613 | 0.100 |
Why?
|
Spectroscopy, Near-Infrared | 2 | 2016 | 721 | 0.100 |
Why?
|
Hydrocarbons, Aromatic | 1 | 2010 | 23 | 0.090 |
Why?
|
Quantum Theory | 1 | 2010 | 70 | 0.090 |
Why?
|
Esters | 1 | 2011 | 210 | 0.090 |
Why?
|
Fibrin | 1 | 2012 | 506 | 0.090 |
Why?
|
Xylenes | 1 | 2009 | 8 | 0.090 |
Why?
|
Iodobenzenes | 1 | 2009 | 24 | 0.090 |
Why?
|
Thermodynamics | 2 | 2010 | 594 | 0.090 |
Why?
|
Rotation | 1 | 2011 | 523 | 0.080 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2009 | 129 | 0.080 |
Why?
|
Administration, Cutaneous | 3 | 2018 | 711 | 0.080 |
Why?
|
Small Molecule Libraries | 1 | 2015 | 720 | 0.080 |
Why?
|
Singlet Oxygen | 2 | 2018 | 53 | 0.080 |
Why?
|
Blood Platelets | 1 | 2019 | 2509 | 0.080 |
Why?
|
Pyrrolidinones | 1 | 2009 | 117 | 0.080 |
Why?
|
Hydrocortisone | 1 | 2016 | 1826 | 0.080 |
Why?
|
Lymphocytes | 1 | 2016 | 2617 | 0.080 |
Why?
|
Nicotine | 1 | 2012 | 681 | 0.080 |
Why?
|
Adjuvants, Immunologic | 1 | 2012 | 1000 | 0.070 |
Why?
|
Mice, Inbred BALB C | 4 | 2018 | 6386 | 0.070 |
Why?
|
Oligopeptides | 1 | 2012 | 1189 | 0.070 |
Why?
|
Erythrocytes | 1 | 2016 | 2455 | 0.070 |
Why?
|
Photochemical Processes | 2 | 2016 | 84 | 0.070 |
Why?
|
Copper | 1 | 2009 | 366 | 0.070 |
Why?
|
Microscopy, Confocal | 1 | 2012 | 1970 | 0.070 |
Why?
|
Amides | 1 | 2009 | 459 | 0.070 |
Why?
|
Wound Infection | 2 | 2018 | 242 | 0.060 |
Why?
|
Molecular Imaging | 1 | 2012 | 828 | 0.060 |
Why?
|
Boronic Acids | 1 | 2009 | 965 | 0.060 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2700 | 0.060 |
Why?
|
Drug Synergism | 2 | 2019 | 1794 | 0.060 |
Why?
|
Swine | 3 | 2022 | 5918 | 0.060 |
Why?
|
Bacteria | 3 | 2021 | 2115 | 0.060 |
Why?
|
Vaccines | 1 | 2012 | 823 | 0.060 |
Why?
|
Hydrogen Peroxide | 2 | 2018 | 730 | 0.060 |
Why?
|
Indoles | 1 | 2012 | 1839 | 0.060 |
Why?
|
Tyrosine | 2 | 2018 | 1462 | 0.060 |
Why?
|
Animals | 14 | 2022 | 168768 | 0.050 |
Why?
|
Venous Thrombosis | 1 | 2012 | 1239 | 0.050 |
Why?
|
Escherichia coli | 3 | 2019 | 4217 | 0.050 |
Why?
|
Macrophages | 1 | 2016 | 5660 | 0.050 |
Why?
|
Ultraviolet Rays | 2 | 2016 | 1060 | 0.050 |
Why?
|
Tissue Distribution | 2 | 2018 | 2327 | 0.050 |
Why?
|
Tumor Microenvironment | 1 | 2012 | 3590 | 0.050 |
Why?
|
Decontamination | 1 | 2019 | 69 | 0.040 |
Why?
|
Mice | 8 | 2021 | 81201 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2012 | 4042 | 0.040 |
Why?
|
Structure-Activity Relationship | 2 | 2015 | 3130 | 0.040 |
Why?
|
Blood Preservation | 1 | 2019 | 177 | 0.040 |
Why?
|
Epinephrine | 1 | 2022 | 792 | 0.040 |
Why?
|
Carboxylic Acids | 1 | 2018 | 97 | 0.040 |
Why?
|
beta-Lactamases | 1 | 2020 | 306 | 0.040 |
Why?
|
Skin Absorption | 1 | 2018 | 94 | 0.040 |
Why?
|
Electron Transport | 1 | 2018 | 211 | 0.040 |
Why?
|
Rolipram | 1 | 2016 | 27 | 0.040 |
Why?
|
Amines | 1 | 2018 | 276 | 0.040 |
Why?
|
Phosphodiesterase 4 Inhibitors | 1 | 2016 | 33 | 0.040 |
Why?
|
Doxapram | 1 | 2015 | 4 | 0.030 |
Why?
|
Vacuum | 1 | 2015 | 65 | 0.030 |
Why?
|
Benzeneacetamides | 1 | 2015 | 39 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2012 | 4839 | 0.030 |
Why?
|
Ligands | 2 | 2015 | 3282 | 0.030 |
Why?
|
Candida albicans | 1 | 2018 | 394 | 0.030 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 2015 | 114 | 0.030 |
Why?
|
Escherichia coli Infections | 1 | 2018 | 532 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13693 | 0.030 |
Why?
|
Kinetics | 2 | 2015 | 6476 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2016 | 743 | 0.030 |
Why?
|
Rats, Inbred F344 | 1 | 2015 | 862 | 0.030 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2016 | 271 | 0.030 |
Why?
|
Sphingosine | 1 | 2016 | 307 | 0.030 |
Why?
|
Type C Phospholipases | 1 | 2015 | 292 | 0.030 |
Why?
|
Caspase 3 | 1 | 2016 | 758 | 0.030 |
Why?
|
Lysophospholipids | 1 | 2016 | 331 | 0.030 |
Why?
|
Diffusion | 1 | 2015 | 832 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2015 | 500 | 0.030 |
Why?
|
COS Cells | 1 | 2015 | 1161 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2016 | 1572 | 0.030 |
Why?
|
Pressure | 1 | 2015 | 1203 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2016 | 18034 | 0.030 |
Why?
|
Metal Nanoparticles | 1 | 2016 | 405 | 0.020 |
Why?
|
Mutagenesis | 1 | 2015 | 1264 | 0.020 |
Why?
|
Half-Life | 1 | 2012 | 661 | 0.020 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2014 | 341 | 0.020 |
Why?
|
Phlebography | 1 | 2012 | 333 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2015 | 1472 | 0.020 |
Why?
|
Ferric Compounds | 1 | 2012 | 374 | 0.020 |
Why?
|
Hydrogen Bonding | 1 | 2010 | 291 | 0.020 |
Why?
|
Molecular Weight | 1 | 2012 | 2255 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2012 | 1420 | 0.020 |
Why?
|
Benzamides | 1 | 2015 | 1379 | 0.020 |
Why?
|
HeLa Cells | 1 | 2016 | 3130 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2010 | 624 | 0.020 |
Why?
|
Chlorides | 1 | 2012 | 667 | 0.020 |
Why?
|
Leukocytes | 1 | 2016 | 2045 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2015 | 1800 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2012 | 2031 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6489 | 0.020 |
Why?
|
Tobacco Use Disorder | 1 | 2012 | 688 | 0.020 |
Why?
|
Binding Sites | 1 | 2015 | 6111 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2016 | 21833 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2020 | 3854 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2010 | 1802 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5953 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4208 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2016 | 3476 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2012 | 6313 | 0.020 |
Why?
|
Burns | 1 | 2016 | 1815 | 0.020 |
Why?
|
Cell Movement | 1 | 2016 | 5218 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2015 | 13814 | 0.010 |
Why?
|
Female | 6 | 2018 | 380193 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 18111 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 16000 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7323 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9724 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 19233 | 0.010 |
Why?
|
Humans | 7 | 2022 | 744366 | 0.010 |
Why?
|
Rats | 1 | 2015 | 24252 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 12073 | 0.010 |
Why?
|
Immunotherapy | 1 | 2012 | 4446 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2012 | 8949 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40075 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23404 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20130 | 0.010 |
Why?
|
Male | 1 | 2012 | 350115 | 0.000 |
Why?
|
Concepts
(187)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_